Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: RockyBalboa who wrote (3983)	11/14/2001 6:43:31 PM
From: Hank	Respond to of 5582

"Gum Tech said in a press release Wednesday it received a perpetual, worldwide, royalty free, fully transferable license to use intellectual property developed for the venture." I bet they hang their "perpetual, worldwide, royalty free, fully transferable license" on the wall in a nice wooden frame, right next to a framed copy of their infamous "clinical study" on Ziscam! I'm going to miss hilarious press releases like this one when they are gone! Thanks for making my day!

To: RockyBalboa who wrote (3983)	11/15/2001 2:15:22 AM
From: Mad2	Read Replies (1) \| Respond to of 5582

Thing is everyone associated with this company makes out but the "shareholders" If anyone who ownes this thing is lucky, mgmt will try and sell the zicam to a consumer products company...instead of ending up like QGLY. Under the terms of the non-binding Memorandum of Understanding, Gum Tech would pay $6.1 million in cash at closing and make four subsequent cash payments of $2.75 million each, spread out over the next two years. Subject to satisfying closing conditions, we believe the transaction will close in the fourth quarter of 2001. Mr. Johnson concluded, ``This transaction will position Gum Tech to control the destiny and better manage the financing of our Zicam operation. In addition, Gum Tech retains significant cash resources which will allow us to build the Zicam brand while continuing to explore other investment opportunities.'' Essentially all the 17 mil from sale of gum business goes to this Zensano (sucessor interest in Bio-delivery), wholely owned sub of Zengen a privatly held Calf firm, bla bla bla......essentially Davidson (these were the orignal Ziacam promoters) et al walk away with 17 mil bucks. mad2